Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Evofem Inc.
With
Neothetics, Inc
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Healthy male or non-pregnant female subjects
Capable of providing written consent.
BMI \< 30 kg/m2
Stable diet and exercise routine
Central abdominal bulging that is evaluated by the clinician at least slight bulge, not flat
You may not be if
Have had any treatment of the fat around your abdomen, including surgical procedures (tummy tuck, liposuction), injections for fat loss or treatments with devices to reduce fat in your abdomen.
Plan on starting a weight loss or exercise program during the study.
Known hypersensitivity to study drugs
Clareo Health | Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat (AbCONTOUR2)
